Adarza BioSystems
St. Peters, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
BW
Bryan WitherbeeExecutive
LM
Linda MeehExecutive
BM
Benjamin MillerNamed on SEC filing
HD
Heiner DreismannNamed on SEC filing
CS
Christopher StriemerNamed on SEC filing
RR
Randolph R. HenkeNamed on SEC filing
TG
Teryl GronwallNamed on SEC filing
Board
JS
Jay SchmelterBoard director
JR
Jenny RookeBoard director
SB
Scott BernsteinBoard director
JM
John McKearn, Ph.D.Board director
DS
David SmollerBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$30.5M disclosed across 4 rounds · 2014–2019
▶$12.8MraisedFeb 2020 · 7 investors · BiotechnologyRule 506(b)
▶$12.8MraisedFeb 2020 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- BRYAN WITHERBEEExecutive Officer, Director
- LARRY PAGEDirector
- JOHN MCKEARNDirector
- BENJAMIN MILLERDirector
- JENNY ROOKEDirector
- JAY SCHMELTERDirector
- DAVID SMOLLERDirector
- Offering amount
- $26.6M
- Amount sold
- $12.8M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.9MraisedJan 2018 · 16 investors · BiotechnologyRule 506(b)
▶$10.9MraisedJan 2018 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bryan WitherbeeExecutive Officer, Director
- Jay SchmelterDirector
- Jenny RookeDirector
- David SmollerDirector
- Linda MeehExecutive Officer
- Scott BernsteinDirector
- Benjamin MillerDirector
- John McKearn, Ph.D.Director
- Offering amount
- $17M
- Amount sold
- $10.9M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.9MraisedMar 2016 · 19 investors · BiotechnologyRule 506(b)
▶$4.9MraisedMar 2016 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew JayDirector
- David SmollerDirector
- Benjamin MillerDirector
- Christopher StriemerExecutive Officer
- Heiner DreismannDirector
- Randolph R. HenkeExecutive Officer, Director, Promoter
- Offering amount
- $7M
- Amount sold
- $4.9M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedJul 2014 · 13 investors · BiotechnologyRule 506(b)
▶$2MraisedJul 2014 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SmollerDirector
- Heiner DreismannDirector
- Christopher StriemerExecutive Officer
- Randolph R. HenkeExecutive Officer, Director, Promoter
- Teryl GronwallExecutive Officer
- Benjamin MillerDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Adarza BioSystems's investors?
- Adarza BioSystems's investors include Hemisphere Ventures LLC.
- How much funding has Adarza BioSystems raised?
- Adarza BioSystems has disclosed $30.5M raised across 4 rounds.
- Where is Adarza BioSystems headquartered?
- Adarza BioSystems is headquartered in St. Peters, US.